Skip to main content
. 2022 Jan 6;11:799566. doi: 10.3389/fonc.2021.799566

Figure 3.

Figure 3

Expression differences of ZCCHC17 in different subgroups in TCGA. (A) ZCCHC17 differentially expressed in different levels of AFP (P <0.05); (B) ZCCHC17 differentially expressed in different tumor status (P <0.05); (C) ZCCHC17 differentially expressed in different groups of vascular invasion(P<0.05); (D) ZCCHC17 differentially expressed in different histologic grade(P<0.001); (E) ZCCHC17 differentially expressed in different groups of the pathological stage (P<0.05). *P < 0.05; ***P < 0.001.